Sio Capital Management as of June 30, 2024
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 48 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 Put Option (INSM) | 24.7 | $91M | 1.4M | 67.00 | |
| Labcorp Holdings Com Shs (LH) | 13.5 | $50M | 246k | 203.51 | |
| Teleflex Incorporated (TFX) | 6.3 | $23M | 111k | 210.33 | |
| Zimmer Holdings (ZBH) | 4.6 | $17M | 155k | 108.53 | |
| Smith & Nephew Spdn Adr New (SNN) | 3.9 | $14M | 580k | 24.78 | |
| Pacira Pharmaceuticals Put Option (PCRX) | 3.5 | $13M | 456k | 28.61 | |
| Organon & Co Common Stock (OGN) | 3.4 | $13M | 608k | 20.70 | |
| GSK Sponsored Adr (GSK) | 3.3 | $12M | 312k | 38.50 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 2.8 | $10M | 225k | 45.25 | |
| Vaxart Com New (VXRT) | 2.7 | $9.9M | 15M | 0.67 | |
| Tyra Biosciences (TYRA) | 2.6 | $9.6M | 600k | 15.99 | |
| Abbott Laboratories (ABT) | 2.5 | $9.3M | 90k | 103.91 | |
| Cigna Corp (CI) | 2.4 | $8.9M | 27k | 330.57 | |
| Kenvue (KVUE) | 2.4 | $8.8M | 485k | 18.18 | |
| Disc Medicine (IRON) | 2.3 | $8.7M | 192k | 45.07 | |
| Erasca (ERAS) | 1.8 | $6.8M | 2.9M | 2.36 | |
| Biodesix (BDSX) | 1.8 | $6.7M | 4.3M | 1.53 | |
| Astria Therapeutics (ATXS) | 1.3 | $4.6M | 510k | 9.10 | |
| Biosante Pharmaceuticals (ANIP) | 1.2 | $4.6M | 72k | 63.68 | |
| Bausch Plus Lomb Corp Common Shares (BLCO) | 1.2 | $4.4M | 303k | 14.52 | |
| Pmv Pharmaceuticals (PMVP) | 1.2 | $4.4M | 2.7M | 1.62 | |
| Zymeworks Del (ZYME) | 1.1 | $4.2M | 491k | 8.51 | |
| Bridgebio Pharma (BBIO) | 0.9 | $3.2M | 125k | 25.33 | |
| Apogee Therapeutics (APGE) | 0.8 | $3.1M | 78k | 39.35 | |
| Context Therapeutics (CNTX) | 0.7 | $2.7M | 1.3M | 2.00 | |
| Modular Med Com New (MODD) | 0.7 | $2.4M | 1.5M | 1.58 | |
| Stoke Therapeutics (STOK) | 0.6 | $2.4M | 175k | 13.51 | |
| Enanta Pharmaceuticals (ENTA) | 0.6 | $2.3M | 177k | 12.97 | |
| Third Harmonic Bio (THRD) | 0.6 | $2.1M | 163k | 13.00 | |
| Nuvation Bio Com Cl A (NUVB) | 0.5 | $2.0M | 668k | 2.92 | |
| Silverback Therapeutics (SPRY) | 0.5 | $1.9M | 218k | 8.51 | |
| Ventyx Biosciences (VTYX) | 0.5 | $1.8M | 779k | 2.31 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.5 | $1.8M | 293k | 6.04 | |
| Arcutis Biotherapeutics (ARQT) | 0.4 | $1.5M | 160k | 9.30 | |
| X4 Pharmaceuticals (XFOR) | 0.4 | $1.4M | 2.5M | 0.58 | |
| Prelude Therapeutics (PRLD) | 0.3 | $1.2M | 320k | 3.81 | |
| Aprea Therapeutics Com New (APRE) | 0.3 | $1.1M | 277k | 4.07 | |
| Rapt Therapeutics (RAPT) | 0.3 | $961k | 315k | 3.05 | |
| Avalo Therapeutics Com New (AVTX) | 0.2 | $891k | 72k | 12.47 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $700k | 122k | 5.75 | |
| Boundless Bio (BOLD) | 0.2 | $627k | 162k | 3.87 | |
| Verastem Com New (VSTM) | 0.1 | $398k | 133k | 2.98 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $354k | 51k | 6.97 | |
| Nextcure (NXTC) | 0.1 | $207k | 130k | 1.59 | |
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.0 | $76k | 254k | 0.30 | |
| Humacyte *w Exp 08/27/202 (HUMAW) | 0.0 | $71k | 50k | 1.41 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $29k | 400k | 0.07 | |
| Caremax *w Exp 06/08/202 | 0.0 | $199.804800 | 13k | 0.02 |
